Vitamin D deficiency and its risk factors in Malaysian children with epilepsy

Choong Yi Fong1, Ann Nie Kong1, Bee Koon Poh2

  • 1Division of Pediatric Neurology, Department of Pediatrics, Faculty of Medicine, University Malaya, Kuala Lumpur, Malaysia.

Epilepsia
|July 6, 2016
PubMed

Insights

Long-term antiepileptic drug use increases vitamin D deficiency risk in children with epilepsy. Malaysian children with epilepsy show high deficiency rates, necessitating targeted supplementation and sun exposure advice.

Area of Science:

  • Pediatric Neurology
  • Endocrinology
  • Public Health

Background:

  • Long-term use of antiepileptic drugs (AEDs) is a known risk factor for vitamin D deficiency.
  • Children with epilepsy are a vulnerable population requiring assessment for nutritional deficiencies.
  • Understanding prevalence and risk factors in specific ethnic groups is crucial for public health initiatives.

Purpose of the Study:

  • To determine the prevalence of vitamin D deficiency and insufficiency in Malaysian children with epilepsy.
  • To identify key risk factors associated with vitamin D deficiency in this population.
  • To inform targeted interventions for preventing vitamin D deficiency.

Main Methods:

  • A cross-sectional study was conducted on 244 children with epilepsy on AEDs for over one year in Malaysian tertiary hospitals.
  • Data collected included demographics, pubertal status, sun exposure, diet, anthropometry, and biochemical markers (25-hydroxy vitamin D, calcium, etc.).
  • Vitamin D deficiency was defined as 25(OH)D ≤35 nmol/L, and insufficiency as 36-50 nmol/L.

Main Results:

  • Overall, 22.5% of children had vitamin D deficiency and 19.7% had insufficiency.
  • Significant risk factors for deficiency included polytherapy (>1 AED), age >12 years, Indian ethnicity, reduced sun exposure (<60 min/day), and being female.
  • Multivariate analysis revealed specific odds ratios for these risk factors.

Conclusions:

  • A substantial proportion of Malaysian children with epilepsy are vitamin D deficient, despite living in a tropical region.
  • Targeted vitamin D supplementation and education on safe sun exposure are recommended for high-risk children.
  • Public health strategies should address nutritional deficiencies in children with epilepsy, considering ethnic and lifestyle factors.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.0K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.2K
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.5K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
904